New to peptides? Start with the foundations ->
The dad-test answer
Oral BPC-157 works for gut healing - that's where the molecule originated, and it's stable in stomach acid. Subcutaneous injection is the protocol the rat tendon studies used; if a reader has tendon, ligament, or musculoskeletal work, injection is the route with the actual animal evidence behind it.
Who wins for what
| Use case | Who wins, and why |
|---|---|
| gut healing, IBS, ulcers, gastritis |
oral capsule BPC-157 was isolated from human gastric juice and is stable in stomach acid - oral delivers it directly to the target tissue. |
| tendon, ligament, joint repair |
subcutaneous injection The Gwyer 2010 Achilles model and every rat tendon study used systemic injection - that's where the evidence actually sits. |
| convenience and adherence |
oral capsule Capsules are easier to remember, easier to travel with, and don't require sourcing bacteriostatic water and syringes. |
| systemic effect for distal injury |
subcutaneous injection Injection delivers measurable plasma levels; oral is local-acting in the gut and may not reach distant tissue at meaningful concentrations. |
What the head-to-head data shows
BPC-157 was originally isolated from human gastric juice - Sikiric et al. 2018 reviews the molecule's stability in stomach acid and its gut-protective mechanism. The peptide is one of the few that survives oral delivery, which is why oral capsules are a real option for gut work. The animal tendon evidence (Gwyer et al. 2010) used systemic intraperitoneal injection in rats; human protocols translate that to subcutaneous near the injury site. Neither route is FDA-approved - this is gray-market off-label for both forms. Compounding pharmacies in the US sell both oral capsules (typically 250-500mcg) and lyophilized vials for reconstitution and subQ injection.
Our honest call
Pick the route that matches the target tissue. For gut symptoms - IBS, leaky gut, ulcers, GERD - the oral capsule is the form with the actual mechanism evidence behind it, and it's the easier protocol to stick with. For tendon, ligament, post-surgical, or musculoskeletal injury, the rat studies and the operator track record both used injection - oral is the second-best option here. We have used oral BPC-157 alongside injection for rotator-cuff recovery; the rotator-cuff result was driven by the injection arm. If a reader is adherence-limited, the oral capsule is still better than nothing. Read the full BPC-157 dosing breakdown for both routes.
Sources and citations
- Sikiric et al., BPC-157 mechanism and oral stability review, Curr Pharm Des 2018 (PMID 29427247)
- Gwyer et al., Achilles tendon repair, J Orthop Res 2010 (PMID 19514371)
- Sikiric et al., BPC-157 in inflammatory bowel disease animal models, J Physiol Pharmacol 2014
- Compounding pharmacy formularies (Tailor Made, Empower)
Where to go next
Subscribe to the dispatch
The weekly Protocol One dispatch covers what's moving in peptides, GLP-1s, and longevity protocols. Free. 5-min read. Broken down for normal humans.
Last reviewed · 2026-05-07 · Page generated by Protocol One matrix engine. None of this replaces a doctor. Peptides are gray-market in the US for most uses. Talk to a real prescriber before you change anything.